Table 4 main predictors of major adverse cardiac events during follow-up identified with univariate analysis
% of MACEs | p value | |
|---|---|---|
Clinical characteristics | ||
Hypertension | 58% versus 23.2% | 0.049 |
LDL-cholesterol > 1.4 mmol/l | 38.7 versus 18.9% | 0.02 |
Absence of high-dose statins therapy* | 17.9% versus 5.48% | 0.03 |
Angiographic ISR characteristics | ||
Early ISR (< 6 months) | 18.1% versus 6.4% | 0.042 |
ISR of the proximal LAD | 14.6% versus 8.9% | 0.032 |
Diffuse ISR | 31% versus 10.3 | 0.05 |
ISR occurring on a BMS | 32.7% versus 20.6% | 0.03 |
Coronary status: triple or double vessel disease | 17.8% versus 4.8% | 0.016 |
Technical aspects of the initial angioplasty | ||
Two or more stents per lesion | 41.5% versus 19.1% | 0.045 |
Absence of post-dilatation | 25.8% versus 3.4% | 0.037 |
ISR treatment strategy | ||
Medical treatment only | 18.8% versus 8.1% | 0.046 |